Digital Therapeutics 2.0
The role of digital therapies in preventing, managing, and treating medical conditions has evolved greatly in the past few years. They may be used independently or taken in tandem with other therapies to optimize clinical outcomes for patients. Further, patients can self-manage these therapies or they can be managed under the direction of a clinician. As innovative therapies are introduced into the market, challenges with developing evidence-based coverage criteria and tracking utilization have been identified. This forum will outline the key barriers and develop solutions to support the appropriate use and coverage of digital therapeutics in the health care system.
This forum identified challenges and payer needs related to the evidence for digital therapeutics. The forum explored the current market space for digital therapeutics including the evidence for the products, place in therapy, monitoring or utilization metrics and barriers that patients face in obtaining therapies.
- Forum Program [PDF]
- Press Release
- Executive Summary
- Forum Webinar
- Forum Proceedings — April/May 2022